In the previous works on the rodent models of both type 1 diabetes and type 2 diabetes, β-estradiol has been shown to protect pancreatic β-cells against oxidative elements and apoptosis, as such findings have inspired researchers to consider pancreatic estrogen receptors as a promising approach for the treatment of diabetes in the future (8). This evidence concerns the gene ESR1 and diabetes mellitus.